1. Hüffmeier, Ulrike, Kraus, Cornelia, Reuter, Miriam S, Reis, André, Zweier, Christiane. 2021. EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum. In Orphanet journal of rare diseases, 16, 136. doi:10.1186/s13023-021-01744-1. https://pubmed.ncbi.nlm.nih.gov/33736665/
2. Docquier, Aurélie, Pavlin, Laura, Raibon, Audrey, Candau, Robin, Bernardi, Henri. 2019. eIF3f depletion impedes mouse embryonic development, reduces adult skeletal muscle mass and amplifies muscle loss during disuse. In The Journal of physiology, 597, 3107-3131. doi:10.1113/JP277841. https://pubmed.ncbi.nlm.nih.gov/31026345/
3. Lee, Ji-Yeon, Kim, Hyun-Ji, Rho, Seung Bae, Lee, Seung-Hoon. . eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells. In Oncotarget, 7, 18541-57. doi:10.18632/oncotarget.8105. https://pubmed.ncbi.nlm.nih.gov/26988917/
4. Moretti, Julien, Chastagner, Patricia, Gastaldello, Stefano, Israël, Alain, Brou, Christel. 2010. The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation. In PLoS biology, 8, e1000545. doi:10.1371/journal.pbio.1000545. https://pubmed.ncbi.nlm.nih.gov/21124883/
5. Cuesta, Rafael, Berman, Adi Y, Alayev, Anya, Holz, Marina K. 2018. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f). In The Journal of biological chemistry, 294, 2267-2278. doi:10.1074/jbc.RA118.004383. https://pubmed.ncbi.nlm.nih.gov/30573685/